Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Endothelial cell 1 (dying 2)
[{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58769/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58769/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58768/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58768/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58799/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58799/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58798/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58798/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58797/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58797/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58796/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58796/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58795/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58795/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58794/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58794/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58793/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58793/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58792/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58792/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58791/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58791/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58790/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58790/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58789/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58789/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58788/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58788/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58787/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58787/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58786/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58786/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58785/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58785/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58784/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58784/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58783/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58783/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58782/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58782/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58781/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58781/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58780/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58780/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58779/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58779/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58778/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58778/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58777/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58777/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58776/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58776/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58775/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58775/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58774/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58774/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58773/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58773/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58772/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58772/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58771/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58771/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58770/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58770/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
endothelial,endothelium,endothelia,blood vessel,vessel,capillary,alveolar,BBB,leaky BBB,blood,lymphatic,lymphatic vessel,circulatory,cardiovascular,circulatory system,cardiovascular system,blood brain barrier,dying,dead,degrade,degradation,die,compromised,necrosis,necrotic,cell death,damaged,disintegrate,disintegration
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
